Search research articles
Contact Us
Filters
Showing results (11-20 of 14) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 14 results.
The Journal of Biological Chemistry
|
March 18, 2026
Hydroxamate-based inhibitors reveal structural determinants of selectivity for Plasmodium falciparum aminopeptidase P
Belinda J Mills, Kyle S Gregory, Gyles E Cozier, et al.
European Journal of Medicinal Chemistry
|
April 16, 2020
Flexible diaminodihydrotriazine inhibitors of Plasmodium falciparum dihydrofolate reductase: Binding strengths, modes of binding and their antimalarial activities
Sumalee Kamchonwongpaisan, Netnapa Charoensetakul, Choladda Srisuwannaket, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 5, 2012
Malarial dihydrofolate reductase as a paradigm for drug development against a resistance-compromised target
Yongyuth Yuthavong, Bongkoch Tarnchompoo, Tirayut Vilaivan, et al.
Antimicrobial Agents and Chemotherapy
|
March 31, 2010
Preclinical evaluation of the antifolate QN254, 5-chloro- N'6'-(2,5-dimethoxy-benzyl)-quinazoline-2,4,6-triamine, as an antimalarial drug candidate
Alexis Nzila, Matthias Rottmann, Penchit Chitnumsub, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 14) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 14 results.
The Journal of Biological Chemistry
|
March 18, 2026
Hydroxamate-based inhibitors reveal structural determinants of selectivity for Plasmodium falciparum aminopeptidase P
Belinda J Mills, Kyle S Gregory, Gyles E Cozier, et al.
European Journal of Medicinal Chemistry
|
April 16, 2020
Flexible diaminodihydrotriazine inhibitors of Plasmodium falciparum dihydrofolate reductase: Binding strengths, modes of binding and their antimalarial activities
Sumalee Kamchonwongpaisan, Netnapa Charoensetakul, Choladda Srisuwannaket, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 5, 2012
Malarial dihydrofolate reductase as a paradigm for drug development against a resistance-compromised target
Yongyuth Yuthavong, Bongkoch Tarnchompoo, Tirayut Vilaivan, et al.
Antimicrobial Agents and Chemotherapy
|
March 31, 2010
Preclinical evaluation of the antifolate QN254, 5-chloro- N'6'-(2,5-dimethoxy-benzyl)-quinazoline-2,4,6-triamine, as an antimalarial drug candidate
Alexis Nzila, Matthias Rottmann, Penchit Chitnumsub, et al.
Page
of 2